Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5584791 | Practical Laboratory Medicine | 2017 | 8 Pages |
Abstract
These results describe the relationship between granulocyte and neutrophil counts, measured on a laboratory analyser, in a large population of patients with malignancies and receiving anti-cancer therapies. However, this relationship must be established using a point of care testing system with a three-part differential count before considering the possibility that a granulocyte count can guide clinical decisions in the absence of a definitive neutrophil count, to reduce the frequency and severity of neutropenic complications in patients receiving cancer treatments.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Nicola S. Pether, Jessica L. Brothwood, Cornelis van Berkel, Elaine H. Dunwoodie, Robert L. Blake, Christopher P. Price, Richard G. Jones, Karl S. Baker, Geoff Hall,